Literature DB >> 7840446

The emergence of Lyme disease and human babesiosis in a changing environment.

A Spielman1.   

Abstract

This pattern of spread of Lyme disease and its vectors in the northeastern United States and Europe derives from the recent proliferation of deer, and the abundance of deer derives from the process of reforestation now taking place throughout the North Temperate Zone of the world. Residential development seems to favor small tree-enclosed meadows interspersed with strips of woodland, a "patchiness" much prized by deer, mice, and humans. As a result, increasingly large numbers of people live where risk of Lyme disease and babesiosis is intense. The agents of these infections, that once were transmitted enzootically by an exclusively rodent-feeding vector, have become zoonotic.

Entities:  

Mesh:

Year:  1994        PMID: 7840446     DOI: 10.1111/j.1749-6632.1994.tb19865.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  42 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Two boundaries separate Borrelia burgdorferi populations in North America.

Authors:  Gabriele Margos; Jean I Tsao; Santiago Castillo-Ramírez; Yvette A Girard; Sarah A Hamer; Anne Gatewood Hoen; Robert S Lane; Steve L Raper; Nicholas H Ogden
Journal:  Appl Environ Microbiol       Date:  2012-06-22       Impact factor: 4.792

3.  Evidence for Personal Protective Measures to Reduce Human Contact With Blacklegged Ticks and for Environmentally Based Control Methods to Suppress Host-Seeking Blacklegged Ticks and Reduce Infection with Lyme Disease Spirochetes in Tick Vectors and Rodent Reservoirs.

Authors:  Lars Eisen; Marc C Dolan
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

Review 4.  Tick-Borne Zoonoses in the United States: Persistent and Emerging Threats to Human Health.

Authors:  Rebecca J Eisen; Kiersten J Kugeler; Lars Eisen; Charles B Beard; Christopher D Paddock
Journal:  ILAR J       Date:  2017-12-15

5.  Lyme disease risk influences human settlement in the wildland-urban interface: evidence from a longitudinal analysis of counties in the northeastern United States.

Authors:  Ashley E Larsen; Andrew J MacDonald; Andrew J Plantinga
Journal:  Am J Trop Med Hyg       Date:  2014-07-21       Impact factor: 2.345

6.  Identification and function of the RNA chaperone Hfq in the Lyme disease spirochete Borrelia burgdorferi.

Authors:  Meghan C Lybecker; Cassandra A Abel; Andrew L Feig; D Scott Samuels
Journal:  Mol Microbiol       Date:  2010-09-27       Impact factor: 3.501

Review 7.  Challenges in the Diagnosis and Treatment of Lyme Disease.

Authors:  Robert T Schoen
Journal:  Curr Rheumatol Rep       Date:  2020-01-07       Impact factor: 4.592

8.  Active and passive surveillance and phylogenetic analysis of Borrelia burgdorferi elucidate the process of Lyme disease risk emergence in Canada.

Authors:  Nicholas H Ogden; Catherine Bouchard; Klaus Kurtenbach; Gabriele Margos; L Robbin Lindsay; Louise Trudel; Soulyvane Nguon; François Milord
Journal:  Environ Health Perspect       Date:  2010-03-25       Impact factor: 9.031

9.  Substantial rise in the prevalence of Lyme borreliosis spirochetes in a region of western Germany over a 10-year period.

Authors:  Helge Kampen; Diana C Rötzel; Klaus Kurtenbach; Walter A Maier; Hanns M Seitz
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

10.  MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi.

Authors:  Gabriele Margos; Anne G Gatewood; David M Aanensen; Klára Hanincová; Darya Terekhova; Stephanie A Vollmer; Muriel Cornet; Joseph Piesman; Michael Donaghy; Antra Bormane; Merrilee A Hurn; Edward J Feil; Durland Fish; Sherwood Casjens; Gary P Wormser; Ira Schwartz; Klaus Kurtenbach
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.